EUVIMEDEUVIMED entdecken
Crossref

Predictive Analysis and Activity Validation of Quality Markers in Erchen Pill

Yingxin Liu iD, Xintian Lu, Qunfang Mao, Yanming Qiu, Lili Liu, Chuanping Feng iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Yingxin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Traditional Chinese Medical College, Zhuzhou, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Hunan "Chuyi" Teaching Master Project, Hunan Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ErChen Pill (ECP), a classical traditional Chinese medicine (TCM), is clinically effective in treating dampness‐phlegm‐related disorders, including cough, nausea, vomiting, and excessive phlegm production. However, the complexity of the chemical composition of traditional Chinese medicine poses challenges to controlling the quality of ECP. This study aimed to predict and validate the quality markers (Q‐markers) of ECP. First, we performed high‐performance liquid chromatography (HPLC) to establish fingerprints of 26 batches of ECP and identify common peaks. Subsequently, quality‐differentiating components were identified by chemometrics, and potential Q‐markers of ECP were further validated through network pharmacology and molecular docking. The five candidate Q‐markers—hesperidin, liquiritin apioside, nobiletin, liquiritin, and tangeretin—were selected via multivariate statistical analysis. The results of network pharmacology analysis and molecular docking revealed that the five candidate Q‐markers acted on multiple targets and pathways, with high binding ability with core targets. Notably, in vitro experiments validated the anti‐tumor effects of liquiritin apioside, which suppressed proliferation and invasion of human prostate cancer PC‐3 cells and induced their apoptosis. In this study, we predicted and validated the Q‐markers of ECP, providing a scientific basis for the comprehensive evaluation of the quality of ECP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalHumansChromatography, High Pressure LiquidMolecular Docking SimulationReproducibility of ResultsNetwork PharmacologyLinear ModelsPC-3 CellsFlavanonesApoptosisCell ProliferationMaleCell Line, Tumor

Stichwörter der Autor:innen

Erchen pillfingerprintnetwork pharmacologyquality markerstraditional Chinese medicine

Substanzen

Drugs, Chinese HerbalFlavanones

Autor:innen und Institutionen

  • Hunan Traditional Chinese Medical College, Zhuzhou, China.

ORCID-Profile: Yingxin Liu, Chuanping Feng

Förderung

  • Hunan "Chuyi" Teaching Master Project
  • Hunan Natural Science Foundation of China

Zitieren

APA

Liu, Y., Lu, X., Mao, Q., Qiu, Y., Liu, L., & Feng, C. (2025). Predictive Analysis and Activity Validation of Quality Markers in Erchen Pill. Biomedical Chromatography. https://doi.org/10.1002/bmc.70163

Vancouver

Liu Y, Lu X, Mao Q, Qiu Y, Liu L, Feng C. Predictive Analysis and Activity Validation of Quality Markers in Erchen Pill. Biomedical Chromatography. 2025. doi:10.1002/bmc.70163

BibTeX
@article{Liu2025,
  author = {Liu, Yingxin and Lu, Xintian and Mao, Qunfang and Qiu, Yanming and Liu, Lili and Feng, Chuanping},
  title = {Predictive Analysis and Activity Validation of Quality Markers in Erchen Pill},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70163}
}
Kostenlos starten →